BioCentury
ARTICLE | Company News

Inhale, Sheffield migraine deal

April 29, 2002 7:00 AM UTC

The companies partnered to develop an inhaled formulation of dihydroergotamine (DHE) to treat migraines. SHM will use its drug delivery technologies in combination with supercritical fluid technology ...